TGFB1 and breast carcinoma: Besides, the results of wound-healing assays and transwell assays showed that 10 ng/mL TGF-β1 significantly increased the invasion and migration of breast cancer cells compared to controls, while Z-GS treatment significantly reduced the migration and invasion abilities of breast cancer cells pretreated with TGF-β1 (Fig. 3A–E).